Zydus Cadila Gets DCGI Nod for Emergency Use of ‘Virafin’ in Treating Moderate COVID-19 Cases
The Drugs Controller General of India (DCGI) on Friday approved the emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, ‘Virafin’ for treating moderate COVID-19 infection in adults.
The Drugs Controller General of India (DCGI) on Friday approved the emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, ‘Virafin’ for treating moderate COVID-19 infection in adults.
(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter (X), Instagram and Youtube. The above post is embeded directly from the user's social media account and LatestLY Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of LatestLY, also LatestLY does not assume any responsibility or liability for the same.)